Both in Pharmaceuticals
Moleculin Biotech vs Lantern Pharma
Over the past year MBRX returned −96.4% and LTRN returned −80.6%; their daily moves had a correlation of -0.03.
MBRX −96.4% LTRN −80.6%Growth of $1, one year, split-adjusted
| Metric | MBRX | LTRN |
|---|---|---|
| Price | $8.75 | $0.7737 |
| Market cap | $8.9M | $11.6M |
| Today | −5.61% | +20.89% |
| 1 month | −16.9% | −28.7% |
| 6 months | −82.6% | −60.9% |
| Year to date | −86.8% | −74.5% |
| 1 year | −96.5% | −80.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.3M | $7.4M |
| Dividend yield | — | — |
| Volatility (60d) | 850.7% | 91.0% |
| Short % of float | 0.7% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).